Pre-clinical in vitro and in vivo studies have identified a number of candidate small molecule inhibitors that target the STAT3 signaling cascade, namely gp130, JAK and STAT3 itself, which inhibit growth and invasion of breast cancer models. The gene discussed is IL6ST; the disease is breast cancer.